Perrigo Company plc announced that Ms. Alison Ives has been promoted to Executive Vice President and Chief Scientific Officer. In this role, Ms. Ives will be responsible for providing global oversight and coordination of Perrigo's research and development, regulatory and innovation efforts. She will join the Company's Operating Committee and report to President and Chief Executive Officer, Murray S. Kessler. Ms. Ives, who joined Perrigo through the acquisition of Omega Pharma in 2015, previously worked for 11 years with AstraZeneca in a variety of regional and global leadership roles within the Scientific office, while sitting on New Product Development Teams across five therapeutic areas. Early in her career, she worked as a laboratory biochemist, researching drug discovery targets before making the move into industry. In 2021, Ms. Ives received a prestigious MBE award from the UK government for services to healthcare, reflecting her lifelong passion to make lives better.